24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Therapix
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:31
KPMG acquires Israeli AI-SAP firm Q.V.
18:06
Bain Capital Ventures taps 26-year-old partner to head Israel activity
16:52
Defense deals on ice as Europe rethinks buying Israeli weapons
14:00
DoorLoop names new R&D and data leaders
More stories
Buzz
Most popular
Daily
Weekly
1
Bain Capital Ventures taps 26-year-old partner to head Israel activity
2
After $400M exit, Medigate’s founders launch new cybersecurity startup
3
From stealth to $3.1 billion in less than a year
4
E-commerce shifts to AI: Yotpo lays off about 200 employees
5
Iron Dome developer Rafael pushes for IPO as rival IAI targets $30 billion market debut
More news
Therapix
4 stories about Therapix
Cannabis Companies Therapix and Destiny to Merge
28.07.19
|
Adi Pick
The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities
Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering
28.03.19
|
Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market